Author(s)

Qingchun Li

Corresponding Author

Qingchun Li

ABSTRACT

Human Papillomavirus (HPV) can bring about many cervical diseases. In China, people become aware of the seriousness of HPV and start to take HPV vaccines. It is around 20.5% of Chinese have HPV-related diseases. However, the quantity of vaccines is in shortage, and the price of vaccines is also quite high for some people. By using literature analysis and comparative analysis methods, this study identifies three essential and intolerable issues about HPV prevalence in China. First, when did HPV vaccines enter the Chinese market, and the prices of HPV vaccines have changed in recent years? Second, the Chinese show varied attitudes towards HPV vaccines compared to developed countries. At last, this study identifies Chinese are more willing to take 9-valent HPV vaccines and why there are fewer HPV vaccines in the Chinese market. Furthermore, the study mainly discusses some methods to solve the high price of HPV vaccines and increase the number of HPV vaccines. This study will give directions to the Chinese government, releasing the burden of paying for vaccines. Besides, after many Chinese HPV vaccines appear, the Chinese will benefit from them, and other countries will also solve the shortage of HPV vaccines.

KEYWORDS

Human Papillomavirus Vaccines, Chinese Market, Human Papillomavirus, Optimized Solutions